Arch Pathol Lab Med

1. OTERO JJ
   The Cognitive Framework Behind Modern Neuropathology.
   Arch Pathol Lab Med. 2024;148:e103-e110.
   

   >> Share

   
   

   
   BMC Cancer

2. SHI MX, Ding X, Tang L, Cao WJ, et al
   PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis.
   BMC Cancer. 2024;24:504.
   

   >> Share

   
   
3. DVORAKOVA K, Skarkova V, Vitovcova B, Soukup J, et al
   Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
   BMC Cancer. 2024;24:509.
   

   >> Share

   
   
4. LIU C, Liu F, Nie D, Xiao Y, et al
   Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma.
   BMC Cancer. 2024;24:521.
   

   >> Share

   
   
5. KUMTHEKAR P, Lyleroehr M, Lacson L, Lukas RV, et al
   A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
   BMC Cancer. 2024;24:527.
   

   >> Share

   
   

   
   Brain

6. NG S, Moritz-Gasser S, Lemaitre AL, Duffau H, et al
   Multivariate mapping of low-resilient neurocognitive systems within and around low-grade gliomas.
   Brain. 2024 Apr 24:awae130. doi: 10.1093.
   

   >> Share

   
   

   
   Childs Nerv Syst

7. DE LAURENTIS C, Pasquali C, Beuriat PA, Mottolese C, et al
   Role of sodium fluorescein in pediatric low-grade glioma surgery: an update.
   Childs Nerv Syst. 2024 Apr 25. doi: 10.1007/s00381-024-06402.
   

   >> Share

   
   
8. ALBALKHI I, Shafqat A, Bin-Alamer O, Mallela AN, et al
   Complications and visual outcomes following surgical resection of pediatric optic pathway/hypothalamic gliomas: a systematic review and meta-analysis.
   Childs Nerv Syst. 2024 Apr 23. doi: 10.1007/s00381-024-06407.
   

   >> Share

   
   
9. CASTIGLIONI G, Vallejos J, Intriago J, Hernandez MI, et al
   Diagnostic support in pediatric craniopharyngioma using deep learning.
   Childs Nerv Syst. 2024 Apr 22. doi: 10.1007/s00381-024-06400.
   

   >> Share

   
   
10. JAIMOVICH SG, Takeuchi K, Testa VT, Okumura E, et al
    Cylinder tumor surgery in pediatric low-grade gliomas.
    Childs Nerv Syst. 2024 Apr 22. doi: 10.1007/s00381-024-06417.
    

    >> Share

    
    
11. PIFFER S, Greto D, Ubaldi L, Mortilla M, et al
    Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma.
    Childs Nerv Syst. 2024 Apr 20. doi: 10.1007/s00381-024-06416.
    

    >> Share

    
    

    
    Clin Cancer Res

12. ABDULLAH KG
    Classifying glioma via liquid biopsy--progress towards an unmet clinical need.
    Clin Cancer Res. 2024 Apr 23. doi: 10.1158/1078-0432.CCR-24-0423.
    

    >> Share

    
    

    
    Eur J Cancer

13. LE RHUN E, Gorlia T, Felsberg J, Jongen J, et al
    Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475].
    Eur J Cancer. 2024 Apr 23:114066. doi: 10.1016/j.ejca.2024.114066.
    

    >> Share

    
    
14. TRAMA A, Botta L, Stiller C, Visser O, et al
    Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.
    Eur J Cancer. 2024;202:113558.
    

    >> Share

    
    

    
    J Neurooncol

15. KOIDE Y, Nagai N, Adachi S, Ito M, et al
    Impact of concurrent antibody-drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study.
    J Neurooncol. 2024 Apr 22. doi: 10.1007/s11060-024-04681.
    

    >> Share

    
    
16. SUN T, Liu B, Cai L, Zhou Y, et al
    Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.
    J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04689.
    

    >> Share

    
    
17. OKAMOTO T, Mizuta R, Takahashi Y, Otani Y, et al
    Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
    J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04628.
    

    >> Share

    
    
18. MAIURI F, Corvino S, Corazzelli G, Del Basso De Caro M, et al
    Single versus multiple reoperations for recurrent intracranial meningiomas.
    J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04673.
    

    >> Share

    
    
19. JOST J, Volker K, Brandt R, Stummer W, et al
    Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04686.
    

    >> Share

    
    
20. PARKER M, Kazemi F, Ahmed AK, Kuo CC, et al
    Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.
    J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04677.
    

    >> Share

    
    
21. WANG S, Zhang D, Wang J, Peng X, et al
    PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
    J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04655.
    

    >> Share

    
    
22. DORON O, Wong T, Ablyazova F, Singha S, et al
    Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
    J Neurooncol. 2024 Apr 26. doi: 10.1007/s11060-024-04647.
    

    >> Share

    
    

    
    J Neuropathol Exp Neurol

23. MACRAE CB, Grieco KC, Solomon IH
    Diagnostic yield of postmortem brain examination following premortem brain biopsy for neoplastic and nonneoplastic disease.
    J Neuropathol Exp Neurol. 2024;83:331-337.
    

    >> Share

    
    
24. MARIET C, Grill J, Ajlil Y, Castel D, et al
    "Hemispheric pilocytic astrocytoma" revisited: A comprehensive clinicopathological and molecular series emphasizing their overlap with other glioneuronal tumors.
    J Neuropathol Exp Neurol. 2024;83:115-124.
    

    >> Share

    
    

    
    J Neurosurg

25. MCDONALD AM, Murdaugh DL, Heinzman KA, Cardan RA, et al
    Longitudinal brain volumetrics in glioma survivors.
    J Neurosurg. 2024 Apr 26:1-8. doi: 10.3171/2024.1.JNS231980.
    

    >> Share

    
    

    
    J Nucl Med

26. ROSEN J, Werner JM, Ceccon GS, Rosen EK, et al
    MRI and (18)F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.
    J Nucl Med. 2024 Apr 25:jnumed.123.266687. doi: 10.2967/jnumed.123.266687.
    

    >> Share

    
    

    
    Neuro Oncol

27. MURPHY ES, Yang K, Suh JH, Yu JS, et al
    Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases.
    Neuro Oncol. 2024 Apr 24:noae076. doi: 10.1093.
    

    >> Share

    
    

    
    Neuroradiology

28. GONCALVES FG, Mahecha-Carvajal ME, Desa A, Yildiz H, et al
    Imaging of supratentorial intraventricular masses in children:a pictorial review- part 1.
    Neuroradiology. 2024 Mar 11. doi: 10.1007/s00234-024-03314.
    

    >> Share

    
    
29. GONCALVES FG, Mahecha-Carvajal ME, Desa A, Yildiz H, et al
    Imaging of supratentorial intraventricular masses in children: a pictorial review-part 2.
    Neuroradiology. 2023 Dec 12. doi: 10.1007/s00234-023-03253.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share